Left ventricular non compaction in children

Congenital Heart Disease

Volumn 5, Issue 5, 2010, Pages 384-397

  Weisz, Sara H ^a,b   Limongelli, Giuseppe ^a   Pacileo, Giuseppe ^a   Calabro, Paolo ^a   Russo, Maria G ^a   Calabro', Raffaele ^a   Vatta, Matteo ^b,c  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b Department of Pediatrics ^*  (United States)

^c TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

Cardio; Left Ventricular; Pediatric

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARDIAC GLYCOSIDE; CYTOSKELETON PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DYSTROBREVIN ALPHA; LAMININ; LAMININ ALPHA; LIM DOMAIN BINDING PROTEIN 3; LOW MOLECULAR WEIGHT HEPARIN; MEXILETINE; SOTALOL; TAFAZZIN; UNCLASSIFIED DRUG; VASODILATOR AGENT; WARFARIN;

ARTICLE; AUTOPSY; AUTOSOMAL DOMINANT INHERITANCE; CARDIAC RESYNCHRONIZATION THERAPY; DEFIBRILLATOR; ECHOCARDIOGRAPHY; EMBOLISM; GENE LOCATION; GENE MUTATION; GENETIC DISORDER; HEART ARRHYTHMIA; HEART FAILURE; HEART FUNCTION; HUMAN; LEFT VENTRICULAR NON COMPACTION; MYOCARDIAL DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PACEMAKER; PHENOTYPE; POSITRON EMISSION TOMOGRAPHY; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PROGNOSIS; THROMBOSIS; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT; INFANT, NEWBORN; ISOLATED NONCOMPACTION OF THE VENTRICULAR MYOCARDIUM; PHENOTYPE; PREDICTIVE VALUE OF TESTS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT; YOUNG ADULT;

EID: 77957172236     PISSN: 1747079X     EISSN: 17470803     Source Type: Journal    
DOI: 10.1111/j.1747-0803.2010.00446.x     Document Type: Article

References (68)

1. Jenni R, Oechslin E, Schneider J, Attenhofer Jost C, Kaufmann PA. Echocardiographic and pathoanatomical characteristics of isolated left ventricular non-compaction: a step towards classification as a distinct cardiomyopathy. Heart 2001, 86:666-671.
2. Bartram U, Bauer J, Schranz D. Primary noncompaction of the ventricular myocardium from the morphogenetic standpoint. Pediatr Cardiol 2007, 28:325-332.
3. Risau W. Mechanisms of angiogenesis. Nature 1997, 386:671-674.
4. Nihei K, Shinomiya N, Kabayama H. Wolff-Parkinson-White (WPW) syndrome in isolated noncompaction of the ventricular myocardium (INVM). Circ J 2004, 68:82-84.
5. Stöllberger C, Finsterer J, Blazek G. Left ventricular hypertrabeculation/noncompaction and association with additional cardiac abnormalities and neuromuscular disorders. Am J Cardiol 2002, 90:899-902.
6. Finsterer J. Cardiogenetics, neurogenetics, and pathogenetics of left ventricular hypertrabeculation/noncompaction. Pediatr Cardiol 2009, 30:659-681.
7. Jenni R, Wyss CA, Oechslin EN, Kaufmann PA. Isolated ventricular noncompaction is associated with coronary microcirculatory dysfunction. J Am Coll Cardiol 2002, 39:450-454.
8. Boyd MT, Seward JB, Tajik AJ, Edwards WD. Frequency and location of prominent left ventricular trabeculations at autopsy in 474 normal human hearts: implications for evaluation of mural thrombi by two-dimensional echocardiography. J Am Coll Cardiol 1987, 9:323-326.
9. Chin TK, Perloff JK, Williams RG, Jue K, Mohrmann R. Isolated noncompaction of left ventricular myocardium. A study of eight cases. Circulation 1990, 82:507-513.
10. Pignatelli RH, McMahon CJ, Dreyer WJ. Clinical characterization of left ventricular noncompaction in children: a relatively common form of cardiomyopathy. Circulation 2003, 108:2672-2678.
11. Finsterer J, Stollberger C. Definite, probable, or possible left ventricular hypertrabeculation/noncompaction. Int J Cardiol 2008, 123:175-176.
12. Kohli SK, Pantazis AA, Shah JS. Diagnosis of left-ventricular non-compaction in patients with left-ventricular systolic dysfunction: time for a reappraisal of diagnostic criteria? Eur Heart J 2008, 29:89-95.
13. Sen-Chowdhry S, McKenna WJ. Left ventricular noncompaction and cardiomyopathy: cause, contributor, or epiphenomenon? Curr Opin Cardiol 2008, 23:171-175.
14. Johnson MT, Zhang S, Gilkeson R. Intrafamilial variability of noncompaction of the ventricular myocardium. Am Heart J 2006, 151:1012.e7-1012.14.
15. McMahon CJ, Pignatelli RH, Nagueh SF. Left ventricular non-compaction cardiomyopathy in children: characterisation of clinical status using tissue Doppler-derived indices of left ventricular diastolic relaxation. Heart 2007, 93:676-681.
16. Bodiwala K, Miller AP, Nanda NC. Live three-dimensional transthoracic echocardiographic assessment of ventricular noncompaction. Echocardiography 2005, 22:611-620.
17. Baker GH, Pereira NL, Hlavacek AM, Chessa K, Shirali G. Transthoracic real-time three-dimensional echocardiography in the diagnosis and description of noncompaction of ventricular myocardium. Echocardiography 2006, 23:490-494.
18. Nemes A, Caliskan K, Geleijnse ML, Soliman OI, Vletter WB, ten Cate FJ. Reduced regional systolic function is not confined to the noncompacted segments in noncompaction cardiomyopathy. Int J Cardiol 2009, 134:366-370.
19. Nemes A, Anwar AM, Caliskan K. Evaluation of left atrial systolic function in noncompaction cardiomyopathy by real-time three-dimensional echocardiography. Int J Cardiovasc Imaging 2008, 24:237-242.
20. Alpendurada F, O'Hanlon R, Prasad SK. Cardiovascular magnetic resonance of cardiomyopathies. Curr Cardiol Rep 2009, 11:61-69.
21. Borreguero LJ, Corti R, de Soria RF, Osende JI, Fuster V, Badimon JJ. Images in cardiovascular medicine. Diagnosis of isolated noncompaction of the myocardium by magnetic resonance imaging. Circulation 2002, 105:E177-E178.
22. Petersen SE, Selvanayagam JB, Wiesmann F. Left ventricular non-compaction: insights from cardiovascular magnetic resonance imaging. J Am Coll Cardiol 2005, 46:101-105.
23. Stöllberger C, Kopsa W, Tscherney R, Finsterer J. Diagnosing left ventricular noncompaction by echocardiography and cardiac magnetic resonance imaging and its dependency on neuromuscular disorders. Clin Cardiol 2008, 31:383-387.
24. Dodd JD, Holmvang G, Hoffmann U. Quantification of left ventricular noncompaction and trabecular delayed hyperenhancement with cardiac MRI: correlation with clinical severity. AJR Am J Roentgenol 2007, 189:974-980.
25. Fazio G, Visconti C, D'Angelo L, Novo G, Novo S. Delayed MRI hyperenhancement in noncompaction: sign of fibrosis correlated with clinical severity. AJR Am J Roentgenol 2008, 190:W273.
26. Ozkutlu S, Bostan O, Karagöz T, Deren O, Tekinalp G. Prenatal diagnosis of isolated non-compaction of the ventricular myocardium: study of six cases. Pediatr Int 2007, 49:172-176.
27. Menon SC, O'Leary PW, Wright GB, Rios R, MacLellan-Tobert SG, Cabalka AK. Foetal and neonatal presentation of noncompacted ventricular myocardium: expanding the clinical spectrum. J Am Soc Echocardiogr 2007, 20:1344-1350.
28. Moura C, Hillion Y, Daikha-Dahmane F. Isolated non-compaction of the myocardium diagnosed in the fetus: two sporadic and two familial cases. Cardiol Young 2002, 12:278-283.
29. Guntheroth W, Komarniski C, Atkinson W, Fligner CL. Criterion for foetal primary spongiform cardiomyopathy: restrictive pathophysiology. Obstet Gynecol 2002, 99:882-885.
30. Bleyl SB, Mumford BR, Brown-Harrison MC. Xq28-linked noncompaction of the left ventricular myocardium: prenatal diagnosis and pathologic analysis of affected individuals. Am J Med Genet 1997, 72:257-265.
31. Ichida F, Hamamichi Y, Miyawaki T. Clinical features of isolated noncompaction of the ventricular myocardium: long-term clinical course, hemodynamic properties, and genetic background. J Am Coll Cardiol 1999, 34:233-240.
32. Wald R, Veldtman G, Golding F, Kirsh J, McCrindle B, Benson L. Determinants of outcome in isolated ventricular noncompaction in childhood. Am J Cardiol 2004, 94:1581-1584.
33. Lofiego C, Biagini E, Ferlito M. Paradoxical contributions of non-compacted and compacted segments to global left ventricular dysfunction in isolated left ventricular noncompaction. Am J Cardiol 2006, 97:738-741.
34. Junga G, Kneifel S, Von Smekal A, Steinert H, Bauersfeld U. Myocardial ischaemia in children with isolated ventricular non-compaction. Eur Heart J 1999, 20:910-916.
35. Steffel J, Kobza R, Oechslin E, Jenni R, Duru F. Electrocardiographic characteristics at initial diagnosis in patients with isolated left ventricular noncompaction. Am J Cardiol 2009, 104:984-989.
36. Celiker A, Ozkutlu S, Dilber E, Karagöz T. Rhythm abnormalities in children with isolated ventricular noncompaction. Pacing Clin Electrophysiol 2005, 28:1198-1202.
37. Salerno JC, Chun TU, Rutledge JC. Sinus bradycardia, Wolff Parkinson White, and left ventricular noncompaction: an embryologic connection? Pediatr Cardiol 2008, 29:679-682.
38. Ichida F. Left ventricular noncompaction. Circ J 2009, 73:19-26.
39. Celiker A, Kafali G, Doǧan R. Cardioverter defibrillator implantation in a child with isolated noncompaction of the ventricular myocardium and ventricular fibrillation. Pacing Clin Electrophysiol 2004, 27:104-108.
40. Koh C, Lee PW, Yung TC, Lun KS, Cheung YF. Left ventricular noncompaction in children. Congenit Heart Dis 2009, 4:288-294.
41. Fazio G, Corrado G, Zachara E. Anticoagulant drugs in noncompaction: a mandatory therapy? J Cardiovasc Med (Hagerstown) 2008, 9:1095-1097.
42. McMahon CJ, Nagueh SF, Pignatelli RH. Characterization of left ventricular diastolic function by tissue Doppler imaging and clinical status in children with hypertrophic cardiomyopathy. Circulation 2004, 109:1756-1762.
43. McMahon CJ, Nagueh SF, Eapen RS. Echocardiographic predictors of adverse clinical events in children with dilated cardiomyopathy: a prospective clinical study. Heart 2004, 90:908-915.
44. Markiewicz-Loskot G, Moric-Janiszewska E, Loskot M, Szydlowski L, Weglarz L, Hollek A. Isolated ventricular non-compaction: clinical study and genetic review. Europace 2006, 8:1064-1067.
45. Xing Y, Ichida F, Matsuoka T. Genetic analysis in patients with left ventricular noncompaction and evidence for genetic heterogeneity. Mol Genet Metab 2006, 88:71-77.
46. Moric-Janiszewska E, Markiewicz-Łoskot G. Genetic heterogeneity of left-ventricular noncompaction cardiomyopathy. Clin Cardiol 2008, 31:201-204.
47. Bione S, D'Adamo P, Maestrini E, Gedeon AK, Bolhuis PA, Toniolo D. A novel X-linked gene, G4.5. is responsible for Barth syndrome. Nat Genet 1996, 12:385-389.
48. http://www.genecards.org/cgi-bin/carddisp.pl?gene=TAZ, Available at: Accessed August 20, 2010
49. Bleyl SB, Mumford BR, Thompson V. Neonatal, lethal noncompaction of the left ventricular myocardium is allelic with Barth syndrome. Am J Hum Genet 1997, 61:868-872.
50. Chen R, Tsuji T, Ichida F. Noncompaction study collaborators. Mutation analysis of the G4.5 gene in patients with isolated left ventricular noncompaction. Mol Genet Metab 2002, 77:319-325.
51. Spencer CT, Bryant RM, Day J. Cardiac and clinical phenotype in Barth syndrome. Pediatrics 2006, 118:e337-e346.
52. Ichida F, Tsubata S, Bowles KR. Novel gene mutations in patients with left ventricular noncompaction or Barth syndrome. Circulation 2001, 103:1256-1263.
53. Singh HR, Yang Z, Siddiqui S. Anovel Alu-mediated Xq28 microdeletion ablates TAZ and partially deletes DNL1L in a patient with Barth syndrome. Am J Medical Gen A 2009, 149A:1082-1085.
54. http://www.genecards.org/cgi-bin/carddisp.pl?gene=DTNA, Available at: Accessed August 20, 2010
55. Faulkner G, Pallavicini A, Formentin E. ZASP: a new Z-band alternatively spliced PDZ-motif protein. J Cell Biol 1999, 146:465-475.
56. Vatta M, Mohapatra B, Jimenez S. Mutations in Cypher/ZASP in patients with dilated cardiomyopathy and left ventricular non-compaction. J Am Coll Cardiol 2003, 42:2014-2027.
57. http://www.genecards.org/cgi-bin/carddisp.pl?gene=LDB3, Available at: Accessed August 20, 2010
58. Marziliano N, Mannarino S, Nespoli L. Barth syndrome associated with compound hemizygosity and heterozygosity of the TAZ and LDB3 genes. Am J Med Genet A 2007, 143A:907-915.
59. Miner JH. Laminins and their roles in mammals. Microsc Res Tech 2008, 71:349-356.
60. http://www.genecards.org/cgi-bin/carddisp.pl?gene=LMNA, Available at: Accessed August 20, 2010
61. Maron BJ, Towbin JA, Thiene G. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 2006, 113:1807-1816.
62. Elliott P, Andersson B, Arbustini E. Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2008, 29:270-276.
63. Klaassen S, Probst S, Oechslin E. Mutations in sarcomere protein genes in left ventricular noncompaction. Circulation 2008, 117:2893-2901.
64. Budde BS, Binner P, Waldmüller S. Noncompaction of the ventricular myocardium is associated with a de novo mutation in the beta-myosin heavy chain gene. PLoS One 2007, 2:e1362.
65. Toyono M, Kondo C, Nakajima Y, Nakazawa M, Momma K, Kusakabe K. Effects of carvedilol on left ventricular function, mass, and scintigraphic findings in isolated left ventricular non-compaction. Heart 2001, 86:E4.
66. Epstein AE, DiMarco JP, Ellenbogen KA. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol 2008, 51:e1-62.
67. Saito K, Ibuki K, Yoshimura N. Successful cardiac resynchronization therapy in a 3-year-old girl with isolated left ventricular non-compaction and narrow QRS complex: a case report. Circ J 2009, 73:2173-2177.
68. Stöllberger C, Finsterer J. Thrombi in left ventricular hypertrabeculation/noncompaction-review of the literature. Acta Cardiol 2004, 59:341-344.